300例肝移植术前患者的糖尿病发病率及特征 - Suppr | 超能文献

相似文献

1

Frequency and characteristics of diabetes in 300 pre-liver transplant patients.300例肝移植术前患者的糖尿病发病率及特征

Nutr Metab Cardiovasc Dis. 2016 May;26(5):441-2. doi: 10.1016/j.numecd.2016.02.015. Epub 2016 Mar 8.

2

Effect of Prediabetes on Allograft Survival and Evolution of New-Onset Diabetes After Transplant in Deceased-Donor Kidney Transplant Recipients During Long-Term Follow-Up.糖尿病前期对长期随访的已故供体肾移植受者移植肾存活及移植后新发糖尿病进展的影响。

Exp Clin Transplant. 2017 Dec;15(6):620-626. doi: 10.6002/ect.2016.0196. Epub 2017 Mar 22.

3

Diabetes based on 2-h plasma glucose among those classified as having prediabetes based on fasting plasma glucose or A1c.在那些基于空腹血糖或糖化血红蛋白被归类为糖尿病前期的人群中，基于2小时血浆葡萄糖的糖尿病情况。

Diab Vasc Dis Res. 2018 Jan;15(1):46-54. doi: 10.1177/1479164117739316. Epub 2017 Nov 7.

4

"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.“沉默”糖尿病与当代药物洗脱支架治疗后临床结局：BIO-RESORT 沉默糖尿病研究。

JACC Cardiovasc Interv. 2018 Mar 12;11(5):448-459. doi: 10.1016/j.jcin.2017.10.038. Epub 2018 Feb 14.

5

Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?肝源性糖尿病：是否应将其与 2 型糖尿病分开？

Liver Int. 2017 Jul;37(7):950-962. doi: 10.1111/liv.13337. Epub 2016 Dec 31.

6

A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.当仅在超重或肥胖患者中测量空腹血浆葡萄糖和/或 HbA1c 时，很大一部分糖尿病前期和糖尿病未被诊断。

Diabetes Metab. 2010 Sep;36(4):312-8. doi: 10.1016/j.diabet.2010.02.004.

7

Back to the future--do IGT and IFG have value as clinical entities?回到未来——糖耐量受损和空腹血糖受损作为临床实体是否有价值？

Diabetes Res Clin Pract. 2008 Aug;81(2):131-3. doi: 10.1016/j.diabres.2008.07.001.

8

Controversies on how diabetes is diagnosed.关于糖尿病诊断的争议。

Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):97-103. doi: 10.1097/MED.0b013e32835168c0.

9

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.射血分数降低的心力衰竭患者中与糖尿病前期和糖尿病相关的风险：血管紧张素受体脑啡肽酶抑制剂与血管紧张素转换酶抑制剂前瞻性比较以确定对心力衰竭试验全球死亡率和发病率影响的见解。

Circ Heart Fail. 2016 Jan;9(1). doi: 10.1161/CIRCHEARTFAILURE.115.002560.

10

Association between microalbuminuria and outcome of non-diabetic population aged 40 years and over: The reaction study.微量白蛋白尿与 40 岁及以上非糖尿病人群结局的关系：反应研究。

Prim Care Diabetes. 2020 Aug;14(4):376-380. doi: 10.1016/j.pcd.2019.12.003. Epub 2019 Dec 23.

引用本文的文献

1

Hepatogenous Diabetes - A Report from Central India.肝源性糖尿病——来自印度中部的一份报告。

J Clin Exp Hepatol. 2022 Mar-Apr;12(2):312-318. doi: 10.1016/j.jceh.2021.08.018. Epub 2021 Aug 25.

2

Hepatogenous Diabetes: A Primer.肝源性糖尿病：入门指南

J Clin Exp Hepatol. 2021 Sep-Oct;11(5):603-615. doi: 10.1016/j.jceh.2021.04.012. Epub 2021 May 1.

3

Hepatocrinology.肝胆病学。